SCHEMBL8796147

SCHEMBL8796147

CCOC(=O)C(c1cccc(F)c1)P(=O)(OCC)OCC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA9 Q16790 1/20 0.48
POLB P06746 2/20 0.46
LMNA P02545 5/20 0.44
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
TDP1 Q9NUW8 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40
GAA P10253 1/20 0.40
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HDAC4 P56524 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20346315 0.84 LMNA (0.47) POLBLMNAMEN1KMT2ASMN1; SMN2
SCHEMBL8796085 0.84 CA12 (0.48) CA12CA1CA2CA9POLB
SCHEMBL8796505 0.83 NPSR1 (0.53) POLBLMNAMEN1KMT2ASMN1; SMN2
SCHEMBL8795832 0.83 LMNA (0.48) CA12CA1CA2CA9POLB
SCHEMBL8555215 0.83 POLB (0.61) POLBLMNAKDM4EMEN1KMT2A
SCHEMBL8959005 0.80 POLB (0.67) CA12CA1CA2CA9POLB
SCHEMBL15645799 0.78 MMP8 (0.50) POLBLMNAMEN1KMT2ASMN1; SMN2
SCHEMBL17724447 0.77 CES2 (0.55) POLBLMNAMEN1KMT2ASMN1; SMN2
SCHEMBL20346311 0.77 MAPT (0.48) CA12CA1CA2CA9POLB
SCHEMBL13194421 0.77 LMNA (0.46) POLBLMNAMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0629604-B1 Alicyclic phospholipase A2 inhibitors BRISTOL MYERS SQUIBB CO (US) 1997-04-16 EP disclosed
US-5436369-A Alicyclic phospholipase A2 inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 1995-07-25 US disclosed
EP-0629604-A2 Alicyclic phospholipase A2 inhibitors Bristol-Myers Company (US) 1994-12-21 EP disclosed